ES2641862T3 - Proceso para la elaboración de inhibidores de CCR3 - Google Patents
Proceso para la elaboración de inhibidores de CCR3 Download PDFInfo
- Publication number
- ES2641862T3 ES2641862T3 ES13712567.0T ES13712567T ES2641862T3 ES 2641862 T3 ES2641862 T3 ES 2641862T3 ES 13712567 T ES13712567 T ES 13712567T ES 2641862 T3 ES2641862 T3 ES 2641862T3
- Authority
- ES
- Spain
- Prior art keywords
- elaboration
- ccr3 inhibitors
- ccr3
- inhibitors
- image
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 102100024167 C-C chemokine receptor type 3 Human genes 0.000 title 1
- 101710149862 C-C chemokine receptor type 3 Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Cephalosporin Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Silver Salt Photography Or Processing Solution Therefor (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12162852 | 2012-04-02 | ||
| EP12162852 | 2012-04-02 | ||
| PCT/EP2013/056638 WO2013149926A1 (en) | 2012-04-02 | 2013-03-28 | Process for the manufacturing of ccr3 inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2641862T3 true ES2641862T3 (es) | 2017-11-14 |
Family
ID=47998462
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES13712567.0T Active ES2641862T3 (es) | 2012-04-02 | 2013-03-28 | Proceso para la elaboración de inhibidores de CCR3 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US8680280B2 (enExample) |
| EP (1) | EP2834229B1 (enExample) |
| JP (1) | JP6255550B2 (enExample) |
| AR (1) | AR090566A1 (enExample) |
| DK (1) | DK2834229T3 (enExample) |
| ES (1) | ES2641862T3 (enExample) |
| TW (1) | TW201400474A (enExample) |
| UY (1) | UY34719A (enExample) |
| WO (1) | WO2013149926A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8278302B2 (en) | 2009-04-08 | 2012-10-02 | Boehringer Ingelheim International Gmbh | Substituted piperidines as CCR3 antagonists |
| UA109290C2 (uk) | 2010-10-07 | 2015-08-10 | Спільні кристали і солі інгібіторів ccr3 | |
| AR090566A1 (es) | 2012-04-02 | 2014-11-19 | Boehringer Ingelheim Int | Proceso para la produccion de inhibidores de crr |
| US10213421B2 (en) | 2012-04-04 | 2019-02-26 | Alkahest, Inc. | Pharmaceutical formulations comprising CCR3 antagonists |
| NZ757769A (en) | 2017-04-05 | 2025-10-31 | Alkahest Inc | Methods and compositions for treating retina-associated disease using ccr3-inhibitors |
| WO2018187503A1 (en) | 2017-04-05 | 2018-10-11 | Alkahest, Inc. | Methods and compositions for treating aging-associated impairments using ccr3-inhibitors |
| AU2019271122A1 (en) | 2018-05-15 | 2020-11-12 | Alkahest, Inc. | Treatment of aging-associated disease with modulators of leukotriene A4 hydrolase |
| US11957671B2 (en) | 2021-11-01 | 2024-04-16 | Alkahest, Inc. | Benzodioxane modulators of leukotriene A4 hydrolase (LTA4H) for prevention and treatment of aging-associated diseases |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE7907121L (sv) | 1979-08-27 | 1981-02-28 | Astra Laekemedel Ab | Ftalimidinderivat |
| JP2807577B2 (ja) | 1990-06-15 | 1998-10-08 | エーザイ株式会社 | 環状アミド誘導体 |
| JPH08134041A (ja) * | 1994-11-10 | 1996-05-28 | Fuji Photo Film Co Ltd | ピラゾールアミド類の製造方法 |
| EP1047675A1 (en) | 1998-01-21 | 2000-11-02 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
| US6140349A (en) | 1998-02-02 | 2000-10-31 | Merck & Co., Inc. | Cyclic amine modulators of chemokine receptor activity |
| JP2002501898A (ja) | 1998-02-02 | 2002-01-22 | メルク エンド カムパニー インコーポレーテッド | ケモカイン受容体活性の環状アミン調節剤 |
| ES2324224T3 (es) | 2004-02-05 | 2009-08-03 | Schering Corporation | Derivados de piperidina que se pueden utilizar como antagonistas ccr3. |
| JP2006137718A (ja) | 2004-11-12 | 2006-06-01 | Astellas Pharma Inc | インドール若しくはインダゾール誘導体 |
| WO2006083390A2 (en) | 2004-12-07 | 2006-08-10 | Children's Hospital Medical Center | Eotaxin-3 in eosinophilic esophagitis |
| DOP2006000051A (es) * | 2005-02-24 | 2006-08-31 | Lilly Co Eli | Inhibidores de vegf-r2 y métodos |
| EP2059515A2 (en) | 2006-04-12 | 2009-05-20 | Pfizer Limited | Pyrrolidine derivatives as modulators of chemokine ccr5 receptors |
| GB0701992D0 (en) | 2007-02-02 | 2007-03-14 | 7Tm Pharma As | Grehlin Receptor Modulators |
| US8008092B2 (en) | 2007-10-09 | 2011-08-30 | University Of Kentucky Research Foundation | CCR3 inhibition for ocular angiogenesis and macular degeneration |
| TW201000446A (en) | 2008-05-30 | 2010-01-01 | Astrazeneca Ab | New compounds useful in pain therapy |
| US8278302B2 (en) | 2009-04-08 | 2012-10-02 | Boehringer Ingelheim International Gmbh | Substituted piperidines as CCR3 antagonists |
| UA109290C2 (uk) | 2010-10-07 | 2015-08-10 | Спільні кристали і солі інгібіторів ccr3 | |
| AR090566A1 (es) | 2012-04-02 | 2014-11-19 | Boehringer Ingelheim Int | Proceso para la produccion de inhibidores de crr |
| US20130261153A1 (en) | 2012-04-03 | 2013-10-03 | Boehringer Ingelheim International Gmbh | Use of ccr3-inhibitors |
| US10213421B2 (en) | 2012-04-04 | 2019-02-26 | Alkahest, Inc. | Pharmaceutical formulations comprising CCR3 antagonists |
-
2013
- 2013-03-27 AR ARP130101059A patent/AR090566A1/es unknown
- 2013-03-27 US US13/851,547 patent/US8680280B2/en active Active
- 2013-03-28 JP JP2015503828A patent/JP6255550B2/ja active Active
- 2013-03-28 DK DK13712567.0T patent/DK2834229T3/da active
- 2013-03-28 EP EP13712567.0A patent/EP2834229B1/en active Active
- 2013-03-28 WO PCT/EP2013/056638 patent/WO2013149926A1/en not_active Ceased
- 2013-03-28 ES ES13712567.0T patent/ES2641862T3/es active Active
- 2013-04-01 TW TW102111742A patent/TW201400474A/zh unknown
- 2013-04-02 UY UY0001034719A patent/UY34719A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20130261307A1 (en) | 2013-10-03 |
| DK2834229T3 (da) | 2017-11-20 |
| UY34719A (es) | 2013-10-31 |
| EP2834229B1 (en) | 2017-08-09 |
| TW201400474A (zh) | 2014-01-01 |
| AR090566A1 (es) | 2014-11-19 |
| EP2834229A1 (en) | 2015-02-11 |
| WO2013149926A1 (en) | 2013-10-10 |
| US8680280B2 (en) | 2014-03-25 |
| JP6255550B2 (ja) | 2018-01-10 |
| JP2015516959A (ja) | 2015-06-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2641862T3 (es) | Proceso para la elaboración de inhibidores de CCR3 | |
| ES2644844T3 (es) | Mecanismo de soporte | |
| CY2024003I1 (el) | Ενωσεις χρησιμες ως αναστολεις κινασης | |
| IL243481A0 (en) | Drug for treatment of nonalcoholic fatty liver disease | |
| PL3209656T3 (pl) | Związki indolo-karboksyamidu użyteczne jako inhibitory kinazy | |
| DK3030323T3 (da) | Kdm1a-inhibitorer til behandlingen af sygdom | |
| PL3181567T3 (pl) | Związki pyrazolopirymidonowe jako inhibitory kinazy | |
| BR112014024897A2 (pt) | Método para amplificar ácidos nucleicos | |
| HUE051767T2 (hu) | Új eljárások oligonukleotidok elõállítására | |
| BR112015023398A2 (pt) | métodos para amplificar ácidos nucléicos | |
| BR112016013492A2 (pt) | processo para a preparação de ácidos alcanossulfônicos. | |
| IL256206A (en) | Mct4 inhibitors for treating disease | |
| FR3039063B1 (fr) | Procede d'enrichissement en pongamol d'huile de karanja | |
| CL2013003563A1 (es) | Compuestos derivados de amidas del ácido gambógico y sus sales; composición farmacéutica que los comprende, útil en el tratamiento del glioblastoma. | |
| LT3219316T (lt) | Riebalų rūgščių mišinys (r.r.g., riebalų rūgščių grupė), skirtas naudoti uždegiminių patologijų gydymui | |
| BR112014028570A2 (pt) | processo para fabricação de compostos de ciclopentilpirimidina hidroxilada. | |
| ITUA20162459A1 (it) | Struttura di supporto per casserature controterra | |
| FR3012447B1 (fr) | Procede de production d'esters (meth)acryliques legers | |
| ES2644847T3 (es) | Máquina agrícola | |
| BR112016008906A2 (pt) | Processo para preparar metil metacrilato | |
| ES2641554T3 (es) | Kit de piezas para colocación de anclaje quirúrgico | |
| EP3004160A4 (en) | PROCESS FOR PREPARING APOLIPOPROTEIN-A-I (APO-A-I) | |
| BR112017012811A2 (pt) | novo tratamento para doenças hepáticas gordurosas não alcoólicas | |
| BR112016019079A2 (pt) | método para a produção de dimetacrilato de glicerol de alta pureza. | |
| ES2600132T9 (es) | Procedimiento para la preparación de estructuras oligoméricas complejas |